Medtronic logo

Medtronic dividend yield (ttm)NYSE: MDT

Dividend yield (TTM)

3.14%
0.00%0.00%

09 November 2024

-23.41%vs 3 years high
+59.39%vs 3 years low
69.14%vs. sector
Performance
Most recent0.0%
1 year-17.8%
3 years+59.4%
5 years+61.9%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend yield (TTM) performance

Most recent change
MDT0.0%
BMY+0.9%
GILD+1.0%
SNY+1.3%
ELV+2.0%
1 year change
MDT-17.8%
BMY+1.6%
GILD-17.5%
SNY-3.9%
ELV+19.8%
3 years change
MDT+59.4%
BMY+33.9%
GILD-25.8%
SNY+5.8%
ELV+48.0%
5 years change
MDT+61.9%
BMY+56.2%
GILD-16.0%
SNY+5.3%
ELV+34.8%

Dividend yield (TTM) performance

MDTBMYGILDSNYELVBSXVRTX
Most recent0.0%+0.9%+1.0%+1.3%+2.0%--
1 year-17.8%+1.6%-17.5%-3.9%+19.8%--
3 years+59.4%+33.9%-25.8%+5.8%+48.0%--
5 years+61.9%+56.2%-16.0%+5.3%+34.8%--
FAQ

What is Medtronic dividend yield (ttm)?

Medtronic dividend yield (ttm) is 3.14%

What is Medtronic dividend yield (ttm) compared to its 3-years maximum value?

Medtronic dividend yield (ttm) is 76.59% of its 3-years maximum value

What is Medtronic dividend yield (ttm) compared to other companies from its sector (Healthcare)?

Medtronic dividend yield (ttm) is higher than 69.14% of the companies in the same sector (Healthcare)

How has Medtronic dividend yield (ttm) changed over the year?

Over the past year, Medtronic dividend yield (ttm) has dropped by 17.8%. During the same period, Bristol-Myers Squibb has increased by 1.6%, Gilead Sciences has decreased by 17.5%, Sanofi has gone down by 3.9%, Elevance Health has increased by 19.8%

How has Medtronic dividend yield (ttm) changed over the 3 years?

During the last 3 years, Medtronic dividend yield (ttm) has increased by 59.4%. Over the same period, Bristol-Myers Squibb has increased by 33.9%, Gilead Sciences has decreased by 25.8%, Sanofi has grown by 5.8%, Elevance Health has increased by 48.0%

How has Medtronic dividend yield (ttm) changed over the 5 years?

For the past 5 years, Medtronic dividend yield (ttm) has increased by 61.9%. In the same period, Bristol-Myers Squibb has increased by 56.2%, Gilead Sciences has decreased by 16.0%, Sanofi has grown by 5.3%, Elevance Health has increased by 34.8%